Comerica Bank
SLRN

Comerica Bank’s ACELYRIN SLRN Stock Holding History

Comerica Bank’s Portfolio SLRN Stock Details SLRN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-1,428
Closed -$4.48K – 3760
2024
Q4 		$4.48K Buy
+1,428
New +$6.91K ﹤0.01% 3336
2024
Q2 		– Sell
-53
Closed -$357 – 3806
2024
Q1 		$357 Buy
+53
New +$403 ﹤0.01% 3694

Other funds holding SLRN

TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
ACMC
AyurMaya Capital Management Company Portsmouth, New Hampshire $148M AUM 24.4% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
MAP
Madison Avenue Partners New York $2.3B AUM 115.82% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
VP
venBio Partners San Francisco, California $281M AUM 261.03% 1-Year Est. Return
VCIM
Velan Capital Investment Management Alpharetta, Georgia $160M AUM 517.12% 1-Year Est. Return
TCM
Tybourne Capital Management Hong Kong $30.9M AUM 20.1% 1-Year Est. Return

Comerica Bank's SLRN Position: Q1 2025 in Review

Comerica Bank sold out of ACELYRIN (SLRN) in Q1 2025, closing a stake of 1,428 shares — an estimated $4.48K sold.

Comerica Bank first reported a position in SLRN in Q1 2024 and held it in 2 quarters. The position peaked at $4.48K in Q4 2024. 105 funds tracked by Wall St. Rank hold SLRN as of Q1 2025.

  • Comerica Bank reported no remaining ACELYRIN position as of Q1 2025 after selling out during the quarter.
  • Comerica Bank sold 1,428 ACELYRIN shares in Q1 2025, an estimated $4.48K.
  • Comerica Bank first reported a position in ACELYRIN in Q1 2024 and held it in 2 quarters.
  • Comerica Bank's ACELYRIN position peaked at $4.48K in Q4 2024.
  • 105 funds tracked by Wall St. Rank held ACELYRIN as of Q1 2025.

Based on Comerica Bank's 13F filing for Q1 2025, filed 14 May 2025.